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Summary
Mac-1 (cxmp 2), a leukocyte adhesion receptor, has been shown in vitro to functionally interact 
with Fey receptors to facilitate immune complex (IC)--stimulated polymorphonuclear neutro­
phil (PMN) functions. To investigate the relevance of Mac-1— FC7 R  interactions in IC-medi- 
ated injury in vivo, we induced a model o f Fc-dependent anti-glomerular basement membrane 
(GBM) nephritis in wild-type and Mac-1—deficient mice by the intravenous injection of anti- 
GBM antibody. The initial glomerular PM N  accumulation, was equivalent in Mac-1 null and 
wild-type mice, but thereafter increased in wild-type and decreased in mutant mice. The ab­
sence of Mac-1 interactions with obvious ligands, intercellular adhesion molecule 1 (ICAM-1), 
and C3 complement, is not responsible for the decrease in neutrophil accumulation in Mac-1— 
deficient mice since glomerular PM N  accumulation in mice deficient in these ligands was 
comparable to those in wild-type mice. In vitro studies showed that spreading of M ac-1-null 
PMNs to IC-coated dishes was equivalent to that o f wild-type PMNs at 5—12 min but was 
markedly reduced thereafter, and was associated with an inability o f mutant neutrophils to re­
distribute filamentous actin. This suggests that in vivo, Mac-1 is not required for the initiation 
of Fc-mediated PM N  recruitment but that M ac-1—Fey R  interactions are required for filamen­
tous actin reorganization leading to sustained P M N  adhesion, and this represents the first dem­
onstration o f the relevance of Mac-1—FcyR interactions in vivo. PMN-dependent proteinuria, 
maximal in wild-type mice at 8  h, was absent in Mac-1 mutant mice at all time points. Comple­
ment C3-deficient mice also had significantly decreased proteinuria compared to wild-type 
mice. Since Mac-1 011 PMNs is the principal ligand for ic3b, an absence of Mac-1 interaction 
with C3 probably contributed to the abrogation o f  proteinuria in M ac-1— null mice.
M ac-1  (am(32, C D llb /C D 1 8 , and complement recep­tor type 3), a (32 integrin present primarily 011 granu­
locytes and monocytes, binds intercellular adhesion molecule
1 (ICAM-1) ,1 an endothelial leukocyte adhesion receptor, 
complement C3 fragment C3bi, matrix molecule heparin, 
and coagulation factors fibrinogen and factor X. It mediates 
several adhesion-dependent processes in leukocytes, such as
'Abbreviations used in this paper: F-actin, filamentous actin; IC, immune com­
plex; ICAM-1, intercellular adhesion molecule 1; GBM, glomerular basement 
membrane; LTB4, leukotriene B.t; PM N, polymorphonuclear neutrophil.
Part o f this work was previously presented as an abstract (1996. J .  Vase.
Res. 33[S1]:A393).
adhesion to the endothelium, phagocytosis, superoxide 
production, and other activation events (1). We have re­
cently demonstrated that mice rendered genetically defi­
cient in Mac-1 are severely compromised in chemoattrac- 
tant leukotriene B4 (LTB4)—induced leukocyte adhesion to 
the vessel wall in vivo (2). M ac-1-deficient murine poly­
morphonuclear neutrophils (PMNs), are unable to phago- 
cytose complement-opsonized particles, have reduced spread­
ing and oxygen radical generation compared to normal 
PMNs, and show an unanticipated defect in PMN apopto- 
sis (2), The role of Mac-1, in these functions presumably 
contributes to the abnormal adhesion, spreading, phagocy­
tosis and genera tion of the oxidative burst in PMNs of patients
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with leukocyte adhesion deficiency type 1 (LAD-1), a disease 
resulting from a congenital deficiency in j32 integrins (1).
Mac-1 also cooperates with Fc*yR to mediate a number 
of neutrophil functional responses after engagement of 
FcyR with immune complexes (ICs). These include IC- 
stimulated phagocytosis, adhesion, and tyrosine phosphory­
lation (3-8). Mac-1 probably mediates these processes by 
directly interacting with FeyR  on the neutrophil surface 
(9-11). This interaction occurs at a site distinct from the 
ligand binding A domain o f Mac-1, probably through the 
COOH-terminal lectin-like domain (9). Mac-1 also associ­
ates with the cytoskeleton during neutrophil interaction
with ICs (5, 7, 10, 12), which may promote IC-stimulated 
PM N functions.
Although the role of M ac-1 in facilitating FcyR-IgG ef­
fector functions has been described in vitro, the in vivo rel­
evance of this interaction has not been previously exam­
ined. W e therefore assessed the role of Mac-1 in acute, 
passive, heterologous anti-glomerular basement membrane 
(GBM) nephritis in which immobilized GBM—anti-GBM 
ICs trigger rapid glomerular PM N  accumulation and PMN- 
dependent leakage of albumin into the urine (13, 14). Im­
portantly, in this model, glomerular neutrophil recruitment 
is Fc-dependent, since (Fab)2 fragments o f this antibody do 
not promote neutrophil accumulation (14). Neutrophil ac­
cumulation is largely complement-independent since C5a- 
deficient mice and cobra venom factor—treated animals still 
exhibit PM N  influx (14, 15). PM N  accumulation is tran­
sient: PMNs remain adherent to the lumen of IC-coated 
vessels (“frustrated phagocytosis”) but then presumably de­
tach and return to the blood stream (16) to meet their fate 
in the spleen or liver. The observed proteinuria has been 
ascribed to cathepsin G and elastase released from PMNs 
accumulated in the glomeruli (17).
In this paper we show that Mac-1 deficiency abrogates 
the peak PM N  accumulation, occurring at 2 h in this 
model, and protects against proteinuria at all time points. 
We present in vitro evidence suggesting that the decrease 
in neutrophil accumulation in M ac-1—deficient mice is due 
to an absence of Mac-1— FeyR  interactions at the neutro­
phil cell surface which are required for firm attachment and 
spreading of neutrophils on ICs. We also report that pro­
teinuria is complement dependent. This suggests that the 
lack of proteinuria in the M ac-1—null mice may result from 
the lack of Mac-1 interaction with the ic3b fragment of 
complement C3, a well described ligand for Mac-1.
Materials and Methods
Animals and Experimental Protocols. Mac-1—deficient mice were 
recently generated by standard gene targeting techniques (2). 
These mice and their wild-type mates are a mixed strain of 129SV 
and C57B1/6. They are bred and maintained in a virus-anti body 
free facility at the Longwood Medical Research Center (Boston, 
MA). Experimental animals were 8—14 wk of age and were sex- 
matched. Both males and females were used. 25% of the experi­
mental mice used at each time point were littermates from het­
erozygous matings. The remainder were the progeny of wild-type
and Mac-1-null homozygous matings. Previously generated mice 
deficient in ICAM-1 (18) were of a pure C57B1/6 background
strain, were 8 wk old, and were age- and sex-matched with their 
wild-type mates. Mice deficient in complement C3 and C4 were 
7—8-wk-old females o f  a mixed 129Sv and C57B1/6 strain. ICAM-1
and complement-deficient mice were bred and maintained in a vi- 
rus-antibody free facility at Harvard Medical School.
Anti-GBM nephritis was induced essentially as previously de­
scribed by our group (13). In brief, preimmune urine was col­
lected ^1 h before injection o f  0.25 ml anti-GBM antiserum per 
mouse (14). At 1, 2, 4, 8 , and 18 h after the injection, urine and 
blood samples (by retroorbital bleed) were collected. Animals 
were then killed and both kidneys were harvested.
Histologic Studies. Kidneys were fixed in 4% paraformalde­
hyde, paraffin-embedded or frozen in OCT compound embedding 
medium (Miles, Inc., Elkhart, IN), and sectioned. 5-jxM paraffin- 
embedded sections were stained for dichloroacetate esterase to 
identify PMNs and tissue was counterstained with nuclear-fast 
red (19). The number of PMNs in 100 glomeruli (50/each kid­
ney) in cross-sections were counted per animal without prior 
knowledge of the genotype of the animal. For electron micros­
copy, glomeruli from one wild-type and one Mac-1-null ne­
phritic animal, 1 h after anti-GBM antibody injection, were ex­
amined by standard techniques. 15 wild-type and Mac-1 -null 
intragiomerular capillary PMNs were examined.
Rabbit anti-GBM antiserum deposition in mouse glomeruli 
was quantitated by immunofluorescence, 4 fxM frozen sections 
prepared from kidneys harvested from wild-type and mutant 
mice 1 h after anti-GBM injections were incubated with a 1:200 
and 1:350 dilution of FITC-tagged secondary antibody (goat 
anti—rabbit, Vector Laboratories Inc., Burlingame, CA). These 
dilutions were saturating as determined by the following method: 
secondary antibody dilutions ranging from 1:1.00 to 1:5,000 were 
applied to wild-type kidney sections and the fluorescence images 
from stained sections were acquired for 0.1 s using Oncor Image 
Analysis software (Oncor, Inc., Gaithersburg, MD), in combina­
tion with a Nikon microphot-FXA microscope and a 12-bit 
cooled CCD SenSys camera (Photometries, Tucson, AZ), to ob­
tain digital images. These digital images were then processed us­
ing a Optimas Image analysis program. An index of fluorescence 
specifically associated with the glomeruli was calculated using an 
Optimas program (designed by Edward Marcus, Ed Marcus Lab­
oratories, Boston, MA) which calculates the following: average 
luminance (filtered) which is defined as the sum of gray levels/ 
number of pixels in the selected region both within selected 
glomeruli (Fg), and in the area within the tubules that is desig­
nated as the background (Bg). The filter function of the program 
is applied to smooth small luminance variations, before detection 
of the primary luminance peak. This was necessary because mea­
surement o f  the staining intensity within the glomeruli might be 
affected by FITC-stained glomerular capillaries present within an 
unstained background. The ratio of Fg over Bg (Fg/Bg) was used 
as an index of fluorescence specifically associated with the glom­
eruli. Plotting of these indices obtained for the serial dilutions of 
secondary antibody assured that secondary antibody dilutions of 
1:200 and 1:350 were saturating. Glomerular cross-sections of wild- 
type and mutant mice were processed with secondary antibody 
dilutions of both these dilutions and analyzed as described above. 
These dilutions gave similar results, therefore only data obtained 
from the 1:200 dilution is shown.
Determination of Urinary Albumin and the Creatinine Concentra- 
Urinary albumin was determined by a double-sandwich 
ELISA as previously detailed (13). Urinary creatinine was quanti­
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tated spectrophotometrically using a commercially available kit
(Sigma Chemical Co., St. Louis, MO). To standardize urine al­
bumin excretion for glomerular filtration rate, proteinuria was 
expressed as microgram of urinary albumin per milligram of uri­
nary creatinine (20).
Isolation of murine PMNs. Peripheral blood was obtained by 
retroorbital sampling and was collected in 5 niM EDTA. Blood 
samples from 6 to 7 mice, typically yielding 6-7 ml of blood, 
were pooled and layered over a Nim.2 neutrophil isolation me­
dium according to manufacturer’s protocols (Cardinal Associates, 
Santa Fe, NM), and referred to as one experimental sample. Red  
cells contaminating the neutrophil preparation were lysed with 
ice-cold 0.2% NaCl. Neutrophils were resuspended in RPMI 
medium.
Adhesion Assay. BSA-anti-BSA ICs and BSA were immobi­
lized on glass coverslips. According to the manufacturer’s techni­
cal information, the BSA (a 35% solution, ICN Pharmaceuticals, 
Inc., Costa Mesa, CA) was heat-shocked, and contained no vi­
tronectin or fibrinogen. Glass coverslips (12 X 12 cm) were 
treated with 0.1 mg/ml poly-D~lysine (mol wt >  70,000, Sigma 
Chemical Co.) for 1 h, treated with 2.5% glutaraldehyde for 15 
min, and washed extensively in ddH20  followed by two PBS 
washes. Coverslips were then coated with 1 mg/ml BSA for 30 
min, washed twice in PBS, incubated with 0.1 M glycine for 2 h 
to quench aldehyde groups, and then incubated with 20 fxg o f  
rabbit anti-BSA IgG (Sigma Chem. Co., St. Louis, MO) in 0.5 
ml o f  PBS for 1 h. This concentration of anti-BSA IgG has been 
previously shown to yield maximum adhesion of human PMNs 
to ICs and LTB4 release from these cells (21). All these proce­
dures were done at room temperature.
Isolated murine PMNs (3—5 X 105cells/well, in 0,6 ml RPMI) 
were placed in 12-well dishes containing coverslips and incubated 
in a 5% C 0 2 incubator at 37°C. At indicated time points, cover- 
slips were washed twice in PBS, fixed with 1.25% glutaraldehyde, 
stained with Giemsa, and mounted on slides with permount. Ad­
herent PMNs were quantitated as follows: the total number o f  
adherent PMNs in 10 high (X40) powered fields (HPF) was de­
termined and expressed as number of adherent cells per HPF. 
This number was then converted to the percentage of control 
binding (set at 100%)), which was that observed for wild-type 
PM Ns incubated with IC-coated coverslips for 5 min. Therefore, 
adherent cells (% control) =  (total bound cells per HPF)/(total 
bound cells per HPF at 5 min for wild-type) X 100%. Spread 
PM Ns were identified as cells with abundant cytoplasm and a 
flattened nucleus and the percentage of spread was determined as 
explained above for determining percentage of adherent PMNs. 
This conversion to percentage of control was necessary since the 
number of murine PMNs isolated from wild-type and mutant 
mice varied between individual experiments, although within the 
same experiment equal numbers of wild-type and mutant PMNs 
were used. Adherence of mouse PMNs to IC and BSA was very 
efficient. For example, for wild-type PMNs, after a 5 and 40 min 
incubation the number of PMNs adherent to IC-coated cover­
slips (144 mm2) was 1.9 ±  0.4 X 105 and 3.2 ± 0.2 X 105, re­
spectively. This represents ^ 4 4  it 4 and 82 ±  21% o f the total 
number of PMNs applied to the coverslip. The number of wild- 
type PMNs adherent to coverslips coated with BSA alone after 5 
and 40 min incubations was 2.1 ±  0.5 X 105 and 2.8 ±  0.5 X 10s, 
respectively, and represented 40 ±  4 and 59 ±  9% o f the total 
number of PMNs applied to the coverslip.
F-Actin Staining. PMNs that adhered to IC-coated glass cov­
erslips for 5 or 40 minutes were stained with rhodamine phalloi- 
din (Molecular Probes, Inc., Eugene, OR) according to manufac­
turer’s protocols. In brief, coverslips were washed in PBS, fixed in 
3.7% formaldehyde/PBS for 10 min, and extracted for 3-5 min 
on ice with 0.1% Triton X-100 buffer, Coverslips were then 
washed in PBS and incubated with 160 nM rhodamine phalloidin 
in PBS for 20 min at room temperature. Coverslips were mounted 
with Cytoseal (Stephens Scientific, Riverdale, NJ) and stored at
4°C.
Quantitation of LTB4. LTB4 levels in media collected from 
PMNs adherent to IC-coated surfaces were quantitated using an 
ELISA assay for murine LTB4 (PerSeptive Diagnostics, Cambridge, 
MA). According to manufacturer’s data, the ELISA assay has a de­
tection limit of 8,9 pg/ml. Its cross-reactivity with other major 
arachidonic acid products, e.g., LTC4, LTD4, LTE4, 5-HETE (hy­
droxy eicosatetraenoic acid), 12-HETE, and 15-HETE, is less than 
1%, as is its cross-activity with LTB4 degradation products 20- 
carboxy-LTB4 and 20-hydroxy-LTB4.
At the indicated time points, medium was collected into ice- 
cold eppendorf tubes and spun at 750 g (4°C) for 10 min to re­
move cells. The supernatants were transferred to fresh ice-cold 
tubes and the ELISA assay was performed in duplicate following 
the manufacturer’s protocol.
Statistics. Data are expressed as mean ±  SEM. Unpaired stu­
dent’s t tests were performed for data and P <0.05 was consid­
ered statistically significant.
Results
M ac-1 Is Required fo r  Glomerular P M N  Accumulation and 
Proteinuria in A n ti-G B M  Nephritis. W e injected anti-GBM 
antibody into M ac-1-deficient mice and their wild-type 
counterparts and measured glomerular neutrophil accumu­
lation and proteinuria, 1 h after anti-serum injection, neu­
trophil glomerular accumulation was the same in null and 
wild-type mice, suggesting that initial PM N recruitment is 
unaffected by Mac-1 deficiency. In contrast, at 2 h, the 
peak of PM N  accumulation in wild-type animals, there 
was a significant reduction in the number of glomerular 
PMNs present in null mice compared with wild-type. The 
difference in glomerular PM N  counts between wild-type 
and mutant mice persisted at 4  h but by 1.8 h the counts de­
clined to baseline levels in mice o f both genotypes (Fig. 1 
A ). The peripheral blood PM N  counts were similar in 
wild-type and null mice at each experimental time point 
(data not shown).
The PM N  accumulation in the glomeruli o f wild-type 
mice was associated with significant proteinuria. Pro­
teinuria appeared at 4 h in wild-type animals and peaked at 
8 h. In contrast, M ac-1—deficient mice failed to develop 
proteinuria at any of the time points examined (Fig. 1 B ). 
Proteinuria is transient in this model and declined in the 
wild-type mice by 18 h. At this time point, proteinuria in 
the mutant mice was still negligible and was significantly 
reduced compared to wild-type.
The decreased PM N  accumulation in null mice cannot 
be attributed to reduced binding o f anti-GBM antibody in 
the glomeruli o f  these mice since a quantitative immuno­
fluorescence analysis o f anti-GBM deposition in the glom­
eruli revealed no differences between wild-type and null 
mice (Table 1). This conclusion is also supported by the
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=  7—10 mice/genotype at time 
points 0-8 h and n =  4 mice/ 
genotype at the 18 h time point. 
*P < 0 .005 , nP <0.05 compared 
to wild-type mice.
fact that neutrophil recruitment at 1 h after anti-GBM in­
jection (Fig. 1 A )  was similar in wild-type and mutant 
mice.
Despite the Absence o f Proteinuria, Endothelial Damage Is Ev­
ident in Glomeruli of Mutant Mice. Glomeruli of kidneys were 
examined by electron microscopy 1 h after anti-GBM in­
jection. In mice of both genotypes, PMNs were observed
Table 1 . Anti-G BM  Antibody Deposition in Wild-type and Mac- 
'1—deficient Glomeruli
Genotype Binding index Average ±  SEM
Wild-type
WT1 14.4
WT2 10.7
WT3 8,7
11.3 ±  1.7
Mac-1-deficient
KOI 15.7
K 02 13.7
KG3 12.2
13.9 ±  1.0
Anti-G BM  antibody b inding index 1 h after intravenous injection o f  
anti-GBM  antiserum. Frozen kidney sections from wild-type and m u­
tant mice were incubated w ith saturating concentration o f  FITC-tagged 
goat anti—rabbit secondary antibody. Fluorescent images w ere digi­
talized and processed w ith  an O ptim a program. T h e  binding index was 
defined as the average fluorescence associated w ith the glomeruli di­
vided by that associated w ithin the tubules. Data are averaged measure­
ments from two sections, four to six glomeruli/animal. There was no 
significant difference in the index associated with glomeruli o f  wild- 
type and m utant mice.
either unattached in the capillary lumen or making contacts 
of varying extents with the GBM, The latter was associated 
with denudation of the fenestrated endothelium (Fig. 2), 
suggesting that Mac-1 deficiency does not protect against 
endothelial denudation by PMNs and that such damage is 
not responsible for the proteinuria in this model. However, 
the lack of proteinuria in Mac-1-deficient mice observed 
in Fig. 1 B  suggests that mutant neutrophils are incapable of 
inducing functional GBM damage leading to proteinuria, 
which is characteristic of wild-type mice.
Mac-1 Ligands, Complement C3, and IC A M - t  Are Not Re­
sponsible for the Reduced Glomerular P M N  Accumulation in 
Mac-1—null Mice. Divalent cation-dependent Mac-1 adhe­
sion to ICAM-1 and iC3b occurs through the A domain of 
Mac-1 (1). To determine whether the engagement of Mac-1 
with complement or ICAM-1 contributes to the reduction 
in PM N accumulation in M ac-1—null mice 2  h after anti- 
GBM antiserum injection, groups of mice genetically deficient 
in C3 (the central component in complement activation), C4 
(the classical pathway of complement activation triggered by 
antigen-antibody complexes), or ICAM-1 were examined
2 h after injection o f anti-GBM antiserum. We observed 
no significant differences in glomerular PMN counts be­
tween ICAM-1—deficient mice and their wild-type mates, 
or C3- and C4-defIcient mice and wild-type mice (Fig. 3). 
These data confirm that neutrophil accumulation is com­
plement-independent (14, 15) and suggest that known Mac-1 
ligands that are most likely to support neutrophil adhesion 
to the vessel wall do not play a role in this process.
However, proteinuria in the C3-deficient mice was sig­
nificantly reduced compared to their wild-type counter­
parts at the 8  h time point (Fig. 3). W e have previously 
shown that Mac-1 is the predominant receptor for C3bi 
since phagocytosis o f complement opsonized particles was 
completely absent in neutrophils isolated from Mac-l-defi-
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WT
Mac-1
Null
Figure 2. Electron micrographs 
o f nephritic wild-type and Mac- 
1-null mice kidneys 1 h after the 
induction o f  anti-GBM nephri­
tis. Representative pictures o f  in- 
tragi oinenilar capillary wild-type 
(top) and Mac- 1-null (bottom) neu­
trophil s are shown. Both sets of 
glomeruli showed denudation of 
the fenestrated endothelium and 
had PMNs directly in contact with 
the GBM. Airoti>hcad, fenestrated 
endothelium; onvtv, GBM; N, 
Neutrophils. Original magnifica­
tion: W T, X I 5,500; Mac-l-null, 
X 13,500.
cient mice (2 ). This suggests that interaction of Mac-1 on To mimic the GBM—anti-GBM interactions in vitro, slides
PM Ns with complement fragment ic3b leads to proteinuria.
T he  next series of in vitro experiments were undertaken 
to address the following hypothesis: equal glomerular PMN 
accumulation in wild-type and mutant mice at 1 h is driven 
by neutrophil Fc receptors engaging immobilized IC, since 
this model is Fc-dependent, but Mac-1 may be required for 
subsequent sustained adhesion and elaboration of chenio- 
kines that promote further PM N recruitment in wild-type 
animals at the 2 h time point (Fig. 1 A).
Sustained Neutrophil Interaction with IC-coated Surfaces R e­
quires Mac-1. We examined adhesion and spreading of 
wild-type and M ac-1— null PMNs on IC-coated surfaces.
were coated with BSA-anti-BSA IgG complexes. The IC- 
coated surfaces were incubated with resting peripheral 
blood PMNs isolated from wild-type and null mice (under 
static conditions) in the absence of serum, thus eliminating 
potential effects o f complement in the assay. The total 
number of adherent cells was measured at 5, 12, 25, and 40 
min. A similar analysis was conducted on PMNs incubated 
with BSA-coated surfaces alone to discern effects due to 
BSA from those that were IC-specific. A time course of to­
tal binding of PM Ns to IC-coated surfaces revealed that 
initial adhesion to IC, within 5 and 12 m in after addition of 
PMNs, was similar in mutant and wild-type mice (Fig. 4).
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Figure  3. Glomerular P M N  accumulation in mice deficient in ICAM-1 
and complement C3 or C4 {A), and proteinuria in C3-deficient mice (J3). 
Auti-GBM nephritis was induced in the aforementioned mice and their 
wild-type counterparts, and glomerular P M N  accumulation was deter­
mined 2 h after the induction o f  nephritis. T he  num ber o f  PMNs per 
glomerular cross-section was not significantly different between any group 
o f  animals and their controls. Proteinuria was examined in C3-deiicient 
mice and their wild-type counterparts 8 h  after induction o f  nephritis. 
C3-null mice had significantly less proteinuria than wild-types, n — 4 for 
each set o f wild-type and complement knockout mice, n =  6 for wild- 
type and ICAM -1—null mice. ffP  <0 .05 .
At 25 and 40 min, wild-type PM Ns continued to accumu­
late on the IC, leading to a >50%  increase over that seen at 
12 min. In Mac-1—null PMNs, the number o f IC-adherent 
PMNs remained the same over a similar time course. Incu-
A
Time (min)
Figure 4, PM N  adhesion to ICs. Isolated wild-type (squares) or Mac-1—null 
(diamonds) PM Ns were incubated with BSA-anti-BSA ICs (A) or BSA 
alone (B), and fixed and stained with W right-Giemsa. The percentage of 
adhesion (i.e., the percentage o f  control that was set as 100% for the adhe­
sion to IC present at 5 min in wild-type cells) was similar in cells of both 
genotypes at 5 and 12 min but decreased significantly in Mac-1—null cells 
at 25 and 40 min. N o  difference was seen between the percentage of 
wild-type and null cells adherent to BSA alone, n =  7 experiments. *P 
<0.005, < 0 .05  compared to wild-type cells.
bation times > 4 0  min did not lead to further enhancement 
in numbers o f adherent PM Ns in either wild-type or mu­
tant samples (data not shown). The number of wild-type 
and mutant PMNs adherent to BSA at 5 or 40 min was 
similar in wild-type and null cells, suggesting that the ob­
served M ac-1-mediated effects are specific for IC-coated 
surfaces (Fig. 4).
Sustained P M N  Spreading and Filamentous Actin Reorgani­
zation on I C  Requires Mac-1. To determine whether spread­
ing of mutant PMNs on 1C was compromised, we detennined 
the percentage o f spread cells in the samples generated in 
Fig. 4, Initial spreading on ICs was the same for wild-type 
and M ac-1-null cells at 5 min. The percentage of spread 
cells increased over time in wild-type cells (Fig. 5 A ), con­
sistent with the increased numbers of PMNs adherent to 
the IC at these later time points as seen in Fig. 4. On the 
other hand, the percentage o f  mutant PMNs spread on IC 
declined rapidly over time and was < 1 0 % of wild-type lev­
els at 40 min (Fig. 5 4^) and <0.03%  at 120 min (data not 
shown). O n BSA-coated surfaces, a difference in spreading 
was observed between wild-type and null cells at 5 min and 
remained constant up to 40 min (Fig. 5 B). This is consis­
tent with previous studies that indicate a role for Mac-1 in 
spreading on BSA (1). The equivalent spreading on ICs at 5 
min versus the difference in spreading seen on BSA-coated 
surfaces at this time point again distinguishes M ac-l-medi- 
ated effects on these two substrates.
To pursue the underlying cause for the decrease in PMN 
spreading in mutant neutrophils, w e examined actin distri­
bution by staining the IC-adherent PMNs for filamentous 
actin (F-actin) (Fig. 5 C). At 5 min, F-actin staining was 
observed in the periphery o f both wild-type and mutant 
neutrophils. By 40 min, wild-type PMNs had extended 
protrusions, increased cell size (spreading), and had a polar­
ized as well as central punctate F-actin staining. In contrast, 
Mac-1—null PMNs at this time point were contracted and 
were much smaller than wild-type PM Ns (which indicates 
a lack of spreading). Several o f the rounded M ac-l-null 
PMNs detached from the dish during processing of the 
sample for rhodamine phalloidin staining. The few that re­
mained at 40 min were the small percentage of spread cells 
that had an actin distribution identical to PMNs adherent 
to IC only for 5 min. We conclude that the actin redistribu­
tion associated with sustained adhesion is compromised in 
M ac-1—deficient PMNs.
P M N  L T B 4 Production Is the Same in W ild-type and Mutant 
P M N s Adherent to IC .  To assess whether the decrease in 
PM N  accumulation at 2 h is caused by inhibition of secre­
tion of a chemoattractant by mutant PMNs, we examined 
the release o f an arachidonic acid metabolite LTB4, since a 
previous study had shown that (32 integrins are required for 
IC-stimulated LTB4 production (21). In addition, LTB4 has 
been linked to the activation and morphologic polarization 
o f PMNs and therefore may be required for sustaining 
PM N spreading. W e measured LTB4 secreted by wild-type 
and mutant PMNs bound to IC-coated surfaces by an 
ELISA assay for murine LTB4. In wild-type PMNs, LTB,, 
was detected in the media at 5 min after neutrophil interac-
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F igure  5. PM N spreading on 
ICs, Samples analyzed in Fig. 4 
were also analyzed for PM N  
.spreading on ICs (A) or BSA alone 
(B) and parallel samples were an­
alyzed for F-actin distribution 
(Q . The spreading in Mac-1-null 
cells (diamonds) and wild-type 
cells was equivalent at 5
min, but was dramatically re­
duced at 25 and 40 m in in null 
cells. Representative Wright Gi- 
emsa-stained slides from the 40 
min time point are shown. Spread- 
ing on BSA was significantly dif­
ferent between wild-type and null 
PMNs at 5 min and remained so 
at 40 minutes. The difference in 
profiles of PMN spreading on 
ICs and BSA alone indicates the 
Mac-1 effects on PM N spreading 
that are iC-specific. * P  <0.005, 
nP <0.05 compared to wild-type 
cells. (Q  Wild-type (WT) and 
Mac-1-null cells adherent to ICs 
for 5 and 40 min were stained 
with rhodamine phalloidin to 
identify F-actin. At 5 min, cells 
o f  both genotypes initiated actin 
polymerization at the periphery 
o f  the cells. By 40 min, wild- 
type PMNs had developed an ac- 
tin-rich surface with a punctate 
cytoplasmic pattern and had visi­
ble projections. In contrast, m u­
tant cells had not progressed to 
this stage and several o f  them had 
rounded up (arrow). Original 
magnification: X473.
tion with IC-coated surfaces and had increased 25-fold by 
40 min (Fig. 6 ). W e detected no significant differences in 
the amount of LTB4 released by wild-type and mutant 
PMNs at all time points tested, suggesting that Mac-1 is not 
required for LTB4 production.
Discussion
This study demonstrates an important role for Mac-1 in 
glomerular PMN accumulation and proteinuria following
the formation of ICs in the GBM. This is consistent with 
conclusions of previous studies using functional blocking an­
tibodies to Mac-1 in acute glomerulonephritis models in 
rats (22, 23). Importantly, in our work, a study o f the ki­
netics of PM N  accumulation revealed that M ac-1 is not re­
quired for the initial PM N  influx at 1 h but is essential for 
further PM N  accumulation and PMN-dependent proteinuria, 
Furthermore, since this model is Fc-dependent (14), our 
results suggest a role for Mac-1 in events downstream of the 
initial Fc-dependent neutrophil recruitment. These down­
stream events are probably not related to the ability of Mac-1
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F ig u re  6. Release o f  LTB4 
from PM Ns incubated with im­
mobilized ICs. T he  amount of 
LTB4 released by wild-type (O ) 
and M ac -1—deficient ( 0 )  
PM N s incubated w ith ICs was 
assessed over the time course 
used for P M N  adhesion and 
spreading. LTB., was rapidly re­
leased (within 5 min) from 
PM N s adherent to ICs and accu­
mulated over time. PM Ns on 
ice, adherent for 40 mill to plas­
tic or BSA (12—40 min) did not
release LTB4 demonstrating that 
its release is stimulated specifi­
cally by ICs. There was no sig­
nificant difference in LT B 4 release between wild-type and null cells incu­
bated with ICs. // =  3 -5  experiments/time point.
to function as an adhesion receptor for obvious ligands: mice 
deficient in Mac-1 ligands, ICAM-1, or complement had 
glomerular PM N  accumulation comparable to wild-type 
mice. This is consistent with other studies which show that 
PM N adhesion to the glomerular endothelium under non- 
static conditions does not require Mac-1 (24). It is not possi­
ble to make analogies of the Fc7 R -M a c - l—mediated PM N 
recruitment model in glomerular capillaries with the multi- 
step paradigm of selectin-induced PM N  rolling, which is 
most relevant at high shear stress (25, 26), followed by firm 
integrin—dependent adhesion seen in venules. This is be­
cause the hemodynamic forces in the glomerular capillaries 
are different than in venules, Additionally, these forces are 
known to be significantly altered during glomerulonephri­
tis, with no measurements of shear stress available under 
these conditions. Finally, leukocyte rolling has not been di­
rectly investigated in glomerular capillaries.
The in vitro study suggests that the decrease in neutro­
phil accumulation in glomeruli o f mutant mice at 2 h is due 
to an inability of mutant PMNs to sustain Fc-mediated ad­
hesion to the immobilized ICs. In vivo this presumably 
leads to their detachment into the bloodstream. Since com­
plement C3 is not involved in PM N  accumulation in vivo, 
the in vitro adhesion assays to ICs were performed in the 
absence of serum, thus eliminating potential effects of com­
plement in the assay. In vitro, we have shown that M ac-1- 
deficient PMNs can initially accumulate and spread on im­
mobilized ICs at wild-type levels, but have a defect in sub­
sequent adhesion and spreading compared to wild-type 
PMNs, Therefore, Mac-1 is not essential for initial FcyR 
attachment to ICs but is required for stabilizing PM N in­
teractions with these complexes. W e also observed a lack of 
F-actin redistribution in M ac-1—deficient PMNs contacting 
ICs. This indicates a role for Mac-1 in actin regulation after 
engagement of ICs, which may be necessary for PMN 
spreading. In fact, Mac-1 has previously been implicated in 
regulating F-actin assembly; Mac-1 is required for tyrosine 
phosphorylation o f the cytoskeletal protein paxillin after 
neutrophil adhesion to ICs (27). Phosphorylation of paxil- 
lin, known to provide a binding site for the SH3 domains
of src family tyrosine kinases, may play a key role in IgG- 
induced signaling (8).
The defect in sustained spreading of mutant PMNs on 
ICs (<10% of wild-type at 40 min) had no effect on release 
of LTB4 from these cells, suggesting that spreading is not 
required for this process. Release o f  LTB4, a potent neutro­
phil chemoattractant produced during PMN interaction 
with ICs, was previously shown to require the (B2 integrins 
(21). Together, these studies suggest that one of the other 
P2 integrins present on neutrophils, LFA-1 or p i 50,95, may 
be required for LTB4 release. The release of other chemoat- 
tractants may be affected in the absence of Fc^R—Mac-1 in­
teractions, thus accounting for the increase in PMN accu­
mulation in wild-type mice, but not in the mutant mice, at 2 h. 
The potential chemoattractants that could be responsible for 
this effect are numerous and were not investigated.
In vivo, a striking absence o f  PMN-dependent pro­
teinuria in M ac-1—null mice was observed despite the wild- 
type levels of PM N accumulation 1 h after induction of ne­
phritis. This is even more significant given that, in electron 
micrographs, the glomeruli o f mutant mice at this time 
point showed similar endothelial denudation as that of 
wild-types, and PMNs were in intimate contact with the 
GBMs. This would suggest that Mac-1-null PMNs are able 
to activate IC-stimulated functions that lead to endothelial 
injury. Indeed, IC-triggered superoxide production (21, 
28) and rise in intracytoplasmic calcium in PMNs (21) do 
not require the (32 integrins. However, events leading to 
GBM damage and subsequent increased permeability to al­
bumin are lacking in mutant PMNs. O ur results in the 
Mac-1-deficient mice are strikingly similar to those obtained 
in beige mice subjected to the same model of anti-GBM 
nephritis (17). Beige mice, which lack cathepsin G and elastase 
in their azurophilic granules, exhibit PM N accumulation 
and glomerular endothelial denudation, as assessed by elec­
tron microscopy, but develop no proteinuria. Similarly, in 
Mac-1—deficient mice, release o f azurophilic granules contain­
ing elastase and cathepsin G may not occur in the mutant 
PMNs and may account for the absence of proteinuria in 
these animals. W e also demonstrate that complement C3— 
deficient mice have decreased proteinuria despite accumu­
lating wild-type levels o f glomerular PMNs. Importantly, 
PM N phagocytosis of complement C3b-opsonized zymo­
san leads to the release of elastase which is Mac-1-dependent 
(29), and we have previously shown that Mac-1-deficient 
PMNs are unable to phagocytose complement-opsonized par­
ticles (2). Therefore, the interaction of Mac-1 on PMNs 
with complement C3 is probably necessary for the release 
of azurophilic granules in our anti-GBM nephritis model 
and explains the lack of proteinuria in both M ac-1-defi­
cient and complement C3—deficient mice. In addition, an­
other group has shown that PMNs extravasated into the 
peritoneum of M ac-1-deficient mice after thioglycollate- 
induced. peritonitis have increased p-glucuronidase con­
tent, suggesting a deficit in release o f azurophilic granules 
by activated Mac-1-null PMNs (30). Although we propose 
that an interaction of M ac-1 with complement is responsi­
ble for proteinuria in this model, a separate role for C3 in
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F ig u re  7. Model o f  putative role o f Mac-1 in IC-stimulated glomerular P M N  recruitment and proteinuria. ( I) Anti-GBM antibody interacts with the 
G B M  forming immobilized ICs. (2) ICs are recognized by F c^R  on PMNs. The adherent neutrophils have actin polymerization occurring at the periph­
ery. This process does not require Mac-1. (3) PMNs adhere to immobilized ICs via the F cyR  and require Mac-1 for reorganization o f  the actin cyto- 
skeleton which promotes sustained spreading on the IC, allowing the PM N s to resist detachment into the flowing blood. Sustained spreading also pro­
m otes release of chemoattractants, which enhances neutrophil influx. (4) Mac-1 interaction with complement C3 leads to the release o f  azurophilic 
granules containing cathepsin G and elastase, which are responsible for GBM  damage, (.5) PM N s detach and return to the bloodstream. In the absence of 
M a c -1 , PMNs adherent to ICs in step 2, detach, and return to the circulating blood as depicted in step 5 and Mac-1/C3~dependent proteinuria does not 
occur. Endo.Fen, endothelial fenestrate; EC, endothelial cell.
generation of a membrane attack complex leading to pro­
teinuria cannot be ruled out and was not explored further 
in this work.
These results suggest the following model for the role of 
Mac-1 in IC-triggered neutrophil accumulation in this 
form  of acute nephritis (Fig. 7). The initial attachment of 
neutrophils to ICs in the glomemlar capillary wall occurs via 
Fc interactions with FcyR on the surface of neutrophils, 
and does not require Mac-1. Thus the early neutrophil ac­
cumulation is equal in both mutant and wild-type mice. 
However, Mac^l, through interactions with, or signals 
from, FcyR, is required for the F-actin reorganization nec­
essary for sustained neutrophil spreading on ICs as shown 
in our in vitro studies. The functional interaction may be 
required for elaboration of mediators that signal further 
neutrophil influx, accounting for the increase in neutrophil 
accumulation in wild-type mice at 2  h, which does not oc­
cur in mutant mice. We have not identified the specific
chemoattractants that are effected by Mac-1 deficiency. 
Production o f LTB4, a powerful neutrophil chemoattrac- 
tant, is not affected by Mac-1 deficiency or PM N  spread­
ing, Interaction of Mac-1 on PMNs with complement iC3b 
deposited on the vessel wall leads to the release o f azuro­
philic granules, leading to pro tease-induced damage to the 
GBM and proteinuria, which is abrogated by M ac-1 or C3 
deficiency. The glomerular PMN accumulation in this 
model is transient. There is evidence to suggest that the 
PMNs detach from the vessel wall, return to the blood­
stream (16), and are probably cleared in the liver or spleen.
In conclusion, this study is the first to suggest a role for 
Mac-1 in FcyR-dependent neutrophil responses in vivo, 
thus providing pathophysiological relevance for Mac-1 in­
teractions with FC7 R. It also demonstrates a crucial role for 
Mac-1 in complement-dependent increased permeability, 
which leads to proteinuria.
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